{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T03:34:41Z","timestamp":1758944081427},"reference-count":10,"publisher":"Walter de Gruyter GmbH","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,27]]},"DOI":"10.1515\/cclm-2020-1884","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T17:53:04Z","timestamp":1620755584000},"page":"e392-e394","source":"Crossref","is-referenced-by-count":2,"title":["Development of chronic myeloid leukemia in a patient previously diagnosed with a JAK2-positive myeloproliferative neoplasm"],"prefix":"10.1515","volume":"59","author":[{"given":"Sander","family":"De Bruyne","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine , AZ Sint-Lucas , Ghent , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Steel","sequence":"additional","affiliation":[{"name":"Department of Haematology , AZ Sint-Lucas , Ghent , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjan","family":"Petrick","sequence":"additional","affiliation":[{"name":"Department of Haematology , AZ Sint-Lucas , Ghent , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Denys","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine , Ghent University Hospital , Ghent , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Vandepoele","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine , Ghent University Hospital , Ghent , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Van Roy","sequence":"additional","affiliation":[{"name":"Department of Biomolecular Medicine , Ghent University Hospital , Ghent , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Degandt","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine , AZ Sint-Lucas , Ghent , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Ghys","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine , AZ Sint-Lucas , Ghent , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henk","family":"Louagie","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine , AZ Sint-Lucas , Ghent , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2021,5,10]]},"reference":[{"key":"2023033111233262248_j_cclm-2020-1884_ref_001","doi-asserted-by":"crossref","unstructured":"Grinfeld, J, Nangalia, J, Baxter, EJ, Wedge, DC, Angelopoulos, N, Cantrill, R, et al.. Classification and personalized prognosis in myeloproliferative neoplasms. N Engl J Med 2018;379:1416\u201330. https:\/\/doi.org\/10.1056\/nejmoa1716614.","DOI":"10.1056\/NEJMoa1716614"},{"key":"2023033111233262248_j_cclm-2020-1884_ref_002","unstructured":"Swerdlow, SH, Campo, E, Harris, NL, Jaffe, ES, Pileri, SA, Stein, H, et al.. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC; 2017."},{"key":"2023033111233262248_j_cclm-2020-1884_ref_003","doi-asserted-by":"crossref","unstructured":"Lorenzo, M, Grille, S, Stevenazzi, M. Emergence of BCR-ABL1 chronic myeloid leukemia in a JAK2-V617F polycythemia vera. J Hematol 2020;9:23\u20139. https:\/\/doi.org\/10.14740\/jh591.","DOI":"10.14740\/jh591"},{"key":"2023033111233262248_j_cclm-2020-1884_ref_004","doi-asserted-by":"crossref","unstructured":"Martin-Cabrera, P, Haferlach, C, Kern, W, Schnittger, S, Haferlach, T. BCR-ABL1-positive and JAK2 V617F-positive clones in 23 patients with both aberrations reveal biologic and clinical importance. Br J Haematol 2017;176:135\u20139. https:\/\/doi.org\/10.1111\/bjh.13932.","DOI":"10.1111\/bjh.13932"},{"key":"2023033111233262248_j_cclm-2020-1884_ref_005","doi-asserted-by":"crossref","unstructured":"Cerquozzi, S, Tefferi, A. Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors. Blood Cancer J 2015;5:e366. https:\/\/doi.org\/10.1038\/bcj.2015.95.","DOI":"10.1038\/bcj.2015.95"},{"key":"2023033111233262248_j_cclm-2020-1884_ref_006","doi-asserted-by":"crossref","unstructured":"Hassankrishnamurthy, S, Mody, MD, Kota, VK. A case of chronic myelogenous leukemia occurring in a patient treated for essential thrombocythemia. Am J Case Rep 2019;20:10\u20134. https:\/\/doi.org\/10.12659\/ajcr.911854.","DOI":"10.12659\/AJCR.911854"},{"key":"2023033111233262248_j_cclm-2020-1884_ref_007","doi-asserted-by":"crossref","unstructured":"Bader, G, Dreiling, B. Concurrent JAK2-positive myeloproliferative disorder and chronic myelogenous leukemia: a novel entity? A case report with review of the literature. J Investig Med High Impact Case Rep 2019;7:2324709619832322. https:\/\/doi.org\/10.1177\/2324709619832322.","DOI":"10.1177\/2324709619832322"},{"key":"2023033111233262248_j_cclm-2020-1884_ref_008","doi-asserted-by":"crossref","unstructured":"Scott, LM, Campbell, PJ, Baxter, EJ, Todd, T, Stephens, P, Edkins, S, et al.. The V617F JAK2 mutation is uncommon in cancers and in myeloid malignancies other than the classic myeloproliferative disorders. Blood 2005;106:2920\u20131. https:\/\/doi.org\/10.1182\/blood-2005-05-2087.","DOI":"10.1182\/blood-2005-05-2087"},{"key":"2023033111233262248_j_cclm-2020-1884_ref_009","doi-asserted-by":"crossref","unstructured":"Pardini, S, Fozza, C, Contini, S, Rimini, E, Ottaviani, E, Amabile, M, et al.. A case of coexistence between JAK2V617F and BCR\/ABL. Eur J Haematol 2008;81:75\u20136. https:\/\/doi.org\/10.1111\/j.1600-0609.2008.01063.x.","DOI":"10.1111\/j.1600-0609.2008.01063.x"},{"key":"2023033111233262248_j_cclm-2020-1884_ref_010","doi-asserted-by":"crossref","unstructured":"Curtin, NJ, Campbell, PJ, Green, AR. The Philadelphia translocation and pre-existing myeloproliferative disorders. Br J Haematol 2005;128:734\u20136. https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05396.x.","DOI":"10.1111\/j.1365-2141.2005.05396.x"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2020-1884\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2020-1884\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T14:41:15Z","timestamp":1680273675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2020-1884\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,10]]},"references-count":10,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,5,14]]},"published-print":{"date-parts":[[2021,9,27]]}},"alternative-id":["10.1515\/cclm-2020-1884"],"URL":"https:\/\/doi.org\/10.1515\/cclm-2020-1884","relation":{},"ISSN":["1434-6621","1437-4331"],"issn-type":[{"value":"1434-6621","type":"print"},{"value":"1437-4331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,10]]}}}